 | | | | The Sackler family owners of Purdue Pharma have proposed a settlement worth up to $6 billion to resolve allegations the company and the owners contributed to the U.S. opioid epidemic, according to a mediator's report. | | | | | | The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. | | | | | | Italy reported 53,662 COVID-19 related cases on Friday, against 57,890 the day before, the health ministry said, while the number of deaths fell to 314 from 320. | | | | | | Steady sales of pacemakers and heart stents may have likely helped Medtronic Plc offset weak demand for its other medical devices, in a quarter that saw an Omicron-led surge in COVID-19 cases and staffing crisis at most U.S. hospitals. | | | | | | Canada has passed the peak of the Omicron variant of COVID-19 and is now in a good shape to handle the pandemic in the future without needing to impose tougher restrictions, chief public health officer Theresa Tam said on Friday. | | | | | | Malaysian researchers found that treatment with the anti-parasite drug ivermectin did not prevent patients with COVID-19 from becoming severely ill in a randomized clinical trial published in the JAMA Internal Medicine journal on Friday. | | | | | | Europe and Africa will work together to resolve by spring a rich-versus-poor nation dispute over how to ensure fair distribution of COVID-19 vaccines and treatments, the head of the European Commission said on Friday. | | | | | | U.S. health regulators delayed the review of Pfizer Inc's COVID-19 vaccine for children under 5 years of age because its two-dose regimen did not work well against the Omicron variant, the Wall Street Journal reported on Friday. | | | | | | British researchers led by Oxford University said on Friday that the current understanding of long COVID and options to treat it is emerging as a major long-term issue for global healthcare systems after reviewing the illness' effects on patients. | | | | | | Atara Biotherapeutics Inc said on Friday that enrolment in an early-stage study of its experimental cancer therapy had been paused after a patient died, sending shares of the drug developer down 12%. | | | | | |
